Quantum Dot-Based Profile Imaging of EPC Subpopulations and Effect on Retinal NV
Quantum Dot-Based Profile Imaging of EPC Subpopulations and Effect on Retinal NV
批准号:
7674575
负责人:
Joshua McAlister Barnett
金额:
$2.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-10-01 至 2012-09-30
关键词:
Animal ModelAntigensAtherosclerosisAttenuatedBiological MarkersBloodBlood CirculationBlood VesselsCD34 geneCardiovascular systemCell Culture TechniquesCell physiologyCell surfaceCellsCodeColorComplexDataDevelopmentDiabetes MellitusDiseaseDisease ProgressionEndothelial CellsEvaluationGrowth FactorHomingImageImaging DeviceIn VitroInflammation MediatorsLaboratoriesLeadMalignant NeoplasmsMapsMethodsModelingMolecularMolecular ProfilingMonoclonal AntibodiesNoiseParticipantPathogenesisPathologyPhenotypePlasticsProductionQuantum DotsRattusRecoveryResearchResolutionRetinalRetinal NeovascularizationRetinopathy of PrematurityRoleScreening procedureSignal TransductionSiteStem cellsStreamSurfaceSurface AntigensSystemTherapeuticTherapeutic InterventionTimeTime StudyTissuesTreatment EfficacyVascular DiseasesVascular Endothelial Growth Factorsangiogenesisbasecell typediabetic ratdiabetic wound healingin vivonanocrystalneovascularneovascularizationneutrophilprogenitorresponsetherapeutic angiogenesistooltrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Endothelial progenitor cells (EPCs) are highly significant participants in the neovascular component of a host of diseases, such as atherosclerosis and cancer. Current research on endothelial progenitor cells has identified several different subpopulations expressing varying phenotypes according to the subset of antigens that are expressed on the cells' surface. Furthermore, evidence is suggestive of varying functions among progenitor cell subpopulations in disease. Specifically, the recruitment of EPCs to sites of neovascularization may be a subpopulation-specific phenomenon. Thus, an elucidation of EPC function based on antigenically-defined subpopulations may facilitate the development of customized, high-efficacy therapeutics aimed at the inhibition or enhancement of EPC function, as well as a more detailed understanding of the role of EPCs in the pathogenesis of numerous diseases. Current in vivo imaging tools to profile the activities of multiple cell subtypes in the circulation have not been developed. We seek to assess the neovascular capacity of various endothelial progenitor subsets using an established animal model of retinopathy of prematurity, in conjunction with a real-time, multispectral, quantum dot nanocrystalbased imaging system which enables a continuous, non-invasive view of the retinal circulation. Our effort is an outgrowth of the Penn laboratory's expertise in the pathogenesis and development of therapeutic interventions of retinopathy of prematurity, as well as the recent effort to isolate and culture distinct EPC subsets. The Haselton laboratory has recently developed a multispectral, real-time imaging tool for the study of multiple cellular and biomolecular mediators of inflammation in a rat model of diabetes. Our approach will use the quantum dot coding of cell subpopulations with varying molecular expression profiles to probe EPC activity in the retinal circulation, thus affording, for the first time, a high-throughput template for the elucidation of EPC function in the context of cell subtypes, as well as the evaluation of therapeutic interventions directed towards these subtypes, in real-time at high spatial and temporal resolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantum Dot-Based Profile Imaging of EPC Subpopulations and Effect on Retinal NV
-
批准号:7333082
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2007
-
负责人:Joshua McAlister Barnett
-
依托单位:
Quantum Dot-Based Profile Imaging of EPC Subpopulations and Effect on Retinal NV
-
批准号:7615060
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2007
-
负责人:Joshua McAlister Barnett
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: